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Abstract
We aimed to investigate the effects of creatine (Cr) supplementation on the plasma lipid profile in
sedentary male subjects undergoing aerobic training.
Methods: Subjects (n = 22) were randomly divided into two groups and were allocated to receive
treatment with either creatine monohydrate (CR) (~20 g·day-1 for one week followed by ~10 g·day-
1 for a further eleven weeks) or placebo (PL) (dextrose) in a double blind fashion. All subjects
undertook moderate intensity aerobic training during three 40-minute sessions per week, over 3
months. High-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL),
very low-density lipoprotein cholesterol (VLDL), total cholesterol (TC), triglyceride (TAG), fasting
insulin and fasting glycemia were analyzed in plasma. Thereafter, the homeostasis model assessment
(HOMA) was calculated. Tests were performed at baseline (Pre) and after four (Post 4), eight (Post
8) and twelve (Post 12) weeks.
Results: We observed main time effects in both groups for HDL (Post 4 versus Post 8; P = 0.01),
TAG and VLDL (Pre versus Post 4 and Post 8; P = 0.02 and P = 0.01, respectively). However, no
between group differences were noted in HDL, LDL, CT, VLDL and TAG. Additionally, fasting
insulin, fasting glycemia and HOMA did not change significantly.
Conclusion: These findings suggest that Cr supplementation does not exert any additional effect
on the improvement in the plasma lipid profile than aerobic training alone.
Introduction
Several recent studies have indicated that creatine (Cr)
supplementation may reduce the symptoms and progres-
sion of certain diseases, including mitochondrial cytopa-
thies [1], neurodegenerative diseases [2] and glucose
intolerance [3]. In addition there is evidence that Cr sup-
plementation may also improve the lipid profile when
combined with exercise training. Kreider et al. [4] reported
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higher plasma HDL-cholesterol levels and lower VLDL-
cholesterol in Cr-supplemented athletes undergoing
resistance and agility-sprint training compared to their
non-supplemented counterparts, while Arciero et al. [5]
reported lowered plasma total cholesterol concentrations
after 28 days of Cr supplementation combined with resist-
ance training. In contrast, Kreider et al [6] did not observe
any changes in the plasma lipid profile of athletes after 21
months of Cr supplementation. However, none of the
aforementioned studies were undertaken with the specific
intention of examining the changes in plasma lipid pro-
file. The designs of these studies did not allow any conclu-
sion regarding possible additive effects of Cr
supplementation on the plasma lipid profile during train-
ing.
To our knowledge, only Earnest et al. [7] reported a spe-
cific effect of Cr supplementation on the plasma lipid pro-
file. This group observed that physically active subjects
with high basal cholesterol levels exhibited a reduction in
blood total cholesterol, triglycerides and VLDL-choles-
terol, after 12 weeks of Cr supplementation. The authors
attributed these changes to a reduction in blood glucose
(P = 0.051) brought about by Cr supplementation.
Reduced blood glucose was interpreted to indicate an
enhancement in insulin sensitivity, which simultaneously
could improve the lipid profile if followed by a reduction
in fasting insulin levels [7]. It is known from other studies
that, changes in glycemia and/or insulinemia may directly
affect blood lipoproteins [8-10].
Pedersen and Saltin [11] have reported that aerobic train-
ing has a positive effect on blood lipoproteins. Independ-
ently, Walsh et al. [12] have indicated in vitro a regulatory
effect of creatine (Cr) and phosphorylcreatine (PCr) on
oxidative phosphorylation in mitochondria which is con-
sistent with a model first proposed by Wyss et al [13], as
well as the boader view that the primary role of the Cr-
PCr/CK system is the regulation of ADP homeostasis [14].
These authors demonstrated that PCr decreases the sensi-
tivity of mitochondrial respiration to ADP whereas Cr has
the opposite effect [12]. Several investigations have
shown increases in Cr content with little or no change in
PCr following Cr supplementation [15,16]. This would
lead to a reduced PCr/Cr ratio, favouring an increase in
intra-mitochondrial [free ADP]. Walsh et al. [12] noted
that a combination of increases in [free ADP] and [Cr] at
rest would elevate mitochondrial respiration and oxida-
tive phosphorylation after Cr supplementation. This
raises the possibility that Cr supplementation could exert
an additive effect to aerobic training on the balance of
lipid and carbohydrate utilisation as fuels during training,
with long term effects on the blood lipoprotein profile.
Theoretically this could provide an explanation for the
positive effects observed by Kreider et al. [4], Arciero et al.
[5] and Earnest et al. [7] (though we note again that no
similar effect was observed by Kreider et al [6]).
We have recently demonstrated that Cr supplementation
and aerobic training have an additive effect on glucose tol-
erance, which could not be attributed to an enhanced
training capacity alone [3]. From this we hypothesized
that the inclusion of Cr during aerobic training may also
affect the plasma lipid profile, particularly in early train-
ing. The aim of this study was therefore to test the possible
synergistic effects of Cr supplementation and aerobic
training on the plasma lipid profile, glucose and insulin
levels in healthy, sedentary, males.
Materials and methods
Subjects
Participants were recruited between August and December
2005 from Sao Paulo, Brazil, through advertisement in
local newspaper and distribution of leaflets to homes.
Respondents were invited to take part in the study if they
were sedentary males (18 – 35 years old) for at least the
past seven years, without pre-existing renal or cardiovas-
cular diseases, eutrophic, non-smoker, and non-vegetar-
ian. Subject details are given in table 1.
The study was approved by the University's ethics com-
mittee and all subjects signed an informed consent form
before participation.
Experimental Protocol
A 12-wk, double-blind, randomized, placebo-controlled
trial was conducted between 1 March and 1 June 2006.
Subjects were randomly assigned to receive either Cr (CR;
n = 12) or placebo (PL; n = 10). Both groups were submit-
ted to moderate intensity aerobic training for three
months. Blood draws were performed prior to training
(Pre), after 4 (Post 4), 8 (Post 8) and 12 weeks (Post 12).
Samples were centrifuged at 4000 rpm, 4°C, for 5 minutes
and stored in a -70°C freezer. We analyzed total choles-
Table 1: Subject characteristics in CR (n = 12) and PL (n = 10) 
groups.
CR group PL group
Age (years) 24.4 ± 5.0 24.2 ± 4.2
BMI (kg·m-2) 23.2 ± 4.6 24.1 ± 3.8
Body Fat Content (%) 17.3 ± 4.1 17.6 ± 3.8
Waist-to-hip ratio (cm) 0.84 ± 0.06 0.83 ± 0.08
Waist circumference (cm) 81.1 ± 8.8 78.3 ± 10
VO2max (ml·kg-1·min-1) 34.6 ± 6.6 35.3 ± 4.3
VT (ml·kg-1·min-1) 32.7 ± 6.2 28.9 ± 5.9
Resting HR (beats·min-1) 66.0 ± 6.2 65.8 ± 7.5
No significant differences were observed between groups (unpaired t 
test). VO2peak = peak oxygen consumption; VT = Ventilatory Gas 
Exchange Threshold; HR = Heart Rate
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terol, triglycerides, HDL-cholesterol, LDL-cholesterol and
VLDL-cholesterol. Fasting plasma insulin and fasting
plasma glucose were also determined and used to esti-
mate homeostasis model assessment (HOMA) index [17]. All
analyses were performed in duplicate and the mean value
was calculated.
Possible differences between groups and changes during
treatment in dietary intake were assessed by three-day 24-
hour dietary recall at baseline and Post 12.
Cr supplementation and blinding
The CR group received 0.3 g (creatine monohydrate)·day-
1·kg -1 of body weight during the first week (loading
phase) and 0.15 g·day-1·kg -1 of body weight for the next
11 weeks (maintenance phase); the PL group was given
dextrose in place of Cr, at the same dose. Body weights
were those measured at the start of the study. This resulted
in absolute doses in high body weight subjects slightly
higher that those usually used for loading and mainte-
nance (see also Discussion). During the loading phase
supplements were presented in four packages, with equal
content, and subjects were instructed to ingest one supple-
ment package at breakfast, lunch and dinner and the
fourth at 10 pm. During the maintenance phase the dose
was divided into two with subjects consuming the supple-
ment during lunch and dinner. The packages were coded
so that neither the investigators nor the participants were
aware of the contents until completion of the analyses. All
subjects were instructed to dissolve the supplements, pref-
erably in juice, in order to mask both the low solubility of
Cr and the taste of dextrose. To evaluate subject blinding,
the questionnaire asked subjects to indicate which treat-
ment they believed they have received (Cr or placebo) at
end of study. The compliance to Cr supplementation was
monitored weekly by personal communication. The sub-
jects completed a weekly questionnaire regarding possible
adverse effects of Cr supplementation (adapted from
Volek et al. [18]).
In order to verify the purity of the Cr used, a sample was
analysed by HPLC [19] and 99.9% purity was established.
VO2peak test
VO2peak was determined using an incremental treadmill
exercise test conducted according to the Bruce protocol.
This test is conducted in three minutes stages. The Bruce
protocol begins with a speed of 2.74 km·hour -1 and a
slope of 10% corresponding to a work rate of approxi-
mately 4.6 METS. Each 3 minutes the workload is
increased by a combination of increasing the speed and
the grade of the treadmill. Attainment of VO2max was
accepted when two of three criteria were met: a plateau in
VO2, a respiratory exchange ratio (RER)> 1.1 and voli-
tional exhaustion. Ventilatory gas exchange threshold
(VT) was determined by the V-slope method[20].
Exercise training
Both groups were submitted to aerobic training, three
times a week, for 40 minutes per session, for 3 months.
Running intensity was set at the corresponding heart rate
of 70% of VO2peak determined by an incremental VO2peak
test. Subjects were requested to run at the pre-set heart rate
during the whole training period. Thus, an increase in
both running distance and running intensity were
expected as training progressed. All sessions were moni-
tored by a fitness-professional. From the outset it was
ruled that subjects would be dropped from the study if
they missed three non-consecutive training sessions, or
two consecutive sessions. One subject from PL group was
excluded for this reason.
Food intake assessment
Food intake was assessed by three 24-hour dietary recalls,
using visual-aid photographs of real foods. Energy and
macronutrient intakes were examined by the Brazilian
software Virtual Nutri®. Additional information was
obtained from the Brazilian Table of Food Composition
(version 1.0, 1997, University of Sao Paulo, Sao Paulo,
SP) When data from particular foods were lacking, data
from a related food was used.
Plasma analyses
Fasting plasma glucose
Fasting plasma glucose was determined by colorimetric
enzymatic assay, with a commercial kit (Glicose Líquido
Estável®, Bioclin, Belo Horizonte).
Fasting plasma insulin
Fasting plasma insulin was determined by radioimmu-
noassay technique (DPC®, Diagnostic Products Corpora-
tion, Los Angeles, CA)
Total cholesterol Level
Total serum cholesterol concentration was determined as
previously described by Kaplan and Pedersen [21], with a
colorimetric enzymatic assay (GPO/POD), and with a
commercial kit aid (CELM® – Colesterol, Sao Paulo).
HDL-cholesterol
HDL-cholesterol was determined according to Finley et al.
[22] using a commercial kit (CELM® – HDL-colesterol, Sao
Paulo).
Triglycerides, VLDL-cholesterol and LDL-cholesterol
Triglycerides were assayed according to Kaplan and Peder-
sen [21], by colorimetric enzymatic assay (GPO/POD),
using a commercial kit (CELM® – Triglicerídeos, Sao
Paulo). From this VLDL-cholesterol (VLDL-cholesterol =
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tryglicerides/5) and LDL-cholesterol (LDL-cholesterol =
total cholesterol - (HDL-cholesterol + VLDL-cholesterol))
concentrations were calculated.
Statistical analyses
SAS® proc Mixed was used to analyze repeated measures
and, when applicable, Tukey Post hoc was used for multi-
ple comparisons. The groups (CR and PL) and periods
(PRE, POST 4, 8 and 12 weeks) were considered fixed fac-
tors and the subjects were assigned as random factors.
For baseline comparisons between the groups two-sample
independent t-test was used. All data is expressed as mean
± SD. The significance level adopted to reject the null
hypothesis was p ≤ 0.05.
Also, SAS® proc IML was used to determine the power of
the statistical tests using a simulation model [23] as sug-
gested by Littell et al. [24]. Expected means and variance
were used as input to simulate lipid profile data using an
autoregressive correlation structure within subjects meas-
urements. Our sample produced a power ranging between
0.8 and 0.9 in the comparison between groups for total
cholesterol, HDL-cholesterol, TAG and VLDL-cholesterol,
the most important dependent variables.
Results
Of the 103 people who responded to the initial request for
volunteers, 79 were excluded as they performed regular
physical activity or expressed self-reported chronic dis-
ease. The remaining 24 subjects were randomly assigned
to the CR or PL groups. Two subjects were subsequently
lost in the PL group: one withdrew for personal reasons
and one was excluded because they missed 2 consecutive
training sessions. Consequently 12 subjects remained in
the Cr group and 10 in the PL group.
There were no differences between or within groups in
both nutrient and energy intake (Table 2). The blinding
was considered successful because the ability of partici-
pants to accurately guess their group assignment was no
better than chance in both groups and was not different
between groups (CR: 43% and PL: 45%, P = 0.89).
Twelve weeks of aerobic training significantly increased
the running distance per session (CR: 42.1 ± 6.3% and PL:
36.8 ± 7.9%, P = 0.05 time main effect). There was also
reduction in body fat content measured by skinfold thick-
ness (CR: -26.6 ± 3% and PL: -25.9 ± 3.9%, P = 0.04) and
resting heart rate (CR: -9.09 ± 2.2% and PL: -8.9 ± 2.8%, P
= 0.05).
Despite the high absolute dose of Cr ingested by subjects
with the highest body weights (compared with ACSM rec-
ommendations in 2000 [25]), there were no reports of
any deleterious effects assessed through the subjective
questionnaire.
Lipid profile values can be found in Figure 1. There was no
significant difference between groups at baseline. How-
ever, there were increases in HDL-cholesterol (Post 4 ver-
sus Post 8; P = 0.01) and decreases in TAG and VLDL-
cholesterol (Pre versus Post 4 and Post 8; P = 0.02 and P =
0.01, respectively) in both groups (main time effect). No
variable was significantly changed with Cr supplementa-
tion (interaction effect).
No significant main effects or differences between groups
were found in fasting glucose, fasting insulin and HOMA
index results (Table 3).
Discussion
As body weights in the CR group ranged from 64.3 to
110.0 kg, absolute doses of Cr given in the first week
ranged from 19.3 to 33.0 g·day-1, with 50% less during
the following eleven weeks. The mean body weight of the
CR group was 83.1 ± 16.3 kg. The dose of 0.3 g·day-1·kg
-1 was chosen to ensure that subjects even at the lowest
body weights received a loading dose close to 20 g per day,
although the same relative dose resulted in a higher load-
ing dose in subjects at the upper end of the weight range.
However, we were cognisant that some authors have sug-
gested that use of a low Cr dose may have been responsi-
Table 2: Food intake by subjects in the CR (n = 12) and PL (n = 10) groups, assessed by three 24-hour dietary recall at baseline and 
after 12 weeks.
CR PL
Pre Post 12 Pre Post 12
Energy (kcal) 2927 ± 321 2891 ± 295 2687 ± 209 2715 ± 216
Protein (%) 29.5 ± 4.3 30.0 ± 2.3 29.3 ± 3.1 30.2 ± 3.7
Lipid (%) 24.9 ± 2.2 25.2 ± 4.3 25.9 ± 4.1 25.8 ± 3.1
Carbohydrate (%) 46.2 ± 5.8 44.3 ± 5.5 44.1 ± 5.8 43.0 ± 4.9
Protein/body weight (g·kg-1) 1.1 ± 0.2 1.2 ± 0.1 1.1 ± 0.3 1.1 ± 0.3
No significant differences were observed (unpaired t test).
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ble for the lack of change in lipid profile in the study of
Volek et al. [18]. The doses of Cr used in this study are
comparable to the fixed dose of 20 g·day-1 used by Arciero
et al. [5] during the first 5 days, and 10 g·day-1 over the
next 3 weeks.
Following the earlier work by Earnest et al. [7] our aim
was to test if Cr supplementation combined with aerobic
training was an effective strategy for the improvement in
the lipid profile in healthy sedentary males. The main
findings were a reduction in triglycerides and VLDL-cho-
lesterol, and an increase in HDL-cholesterol, after moder-
ate intensity aerobic training (main time effect). However,
Cr supplementation had no further effect on lipid profile
improvement. It is important to note that we did not test
the effect of aerobic training per se on lipid profile. We
tested for a possible additive effect of Cr supplementation
on the previously described improvement in lipid profile
after aerobic training [26,27].
Our findings do not agree with those of Earnest et al. [7].
The differences between studies may have arisen from dif-
ferences in their research design. Earnest et al. [7] selected
hypercholesterolemic men and women (those with total
cholesterol levels higher than 200 mg/dl), while we inves-
tigated healthy sedentary males. Thus, it was expected
from the outset that a lower adaptative response would be
shown by our subjects since their baseline values were
Effects of Cr supplementation in conjunction with aerobic training on blood triglycerides, VLDL-cholesterol, total cholesterol, LDL-ch lesterol and HDL-cholesterol at baseline (Pre) and after 4 (Post 4), 8 (Post 8), and 12 (Post 12) weeks of interventionFigure 1
Effects of Cr supplementation in conjunction with aerobic training on blood triglycerides, VLDL-cholesterol, 
total cholesterol, LDL-cholesterol and HDL-cholesterol at baseline (Pre) and after 4 (Post 4), 8 (Post 8), and 
12 (Post 12) weeks of intervention. * main time effect: Post 4 versus Post 8 (p = 0.01); * * main time effect: Pre versus 
Post 8 and Post 12 (p = 0.02 and p = 0.01, respectively). No significant interaction effects were observed between the CR (n = 
12) and PL (n = 10) groups.
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within the normal range (see figure 1, baseline data). In
addition, Earnest et al. [7] stated that Cr supplementation
reduced triglycerides and VLDL-cholesterol levels at week
four, and maintained them up to week 12, compared to
baseline values (-23%, -22% and -26%, after 4, 8 and 12
weeks, respectively). However, the Cr and placebo groups
had different baseline values. Thus, this difference impairs
the comparison between groups as is not possible to dis-
tinguish between a true treatment effect from a distinct
response due to a baseline difference.
Earnest et al. [7] also reported a decreased fasting glucose
trend (P = 0.051). According to the authors, such a
decrease indicated a possible improvement in insulin sen-
sitivity, which would cause a better lipid profile particu-
larly if followed by a reduction in the fasting insulin
levels. However, our results and others [28,29] have
shown neither a significant improvement in insulin sensi-
tivity nor a decrease in fasting glucose, after Cr supple-
mentation. In light of these findings, we may suggest two
explanations: 1) Cr supplementation has no effect on
insulin sensitivity, or 2) Cr supplementation does
improve insulin sensitivity slightly, but not enough to
enhance the lipid profile in healthy subjects. As we [3] and
others [28,30] have demonstrated that Cr supplementa-
tion may increase both glucose tolerance and glycogen
content, we consider the latter hypothesis more plausible.
Ferrante et al. [2] indicated that Cr intake can ameliorate
hyperglycaemia, typical of transgenic Huntington disease
mice, delaying the onset of diabetes. Supporting these
findings, Eijnde et al. [31] verified that Cr ingestion can
reduce the insulinogenic index in an animal model of
inherited type 2 diabetes. Taken together, these results
suggest that Cr might exert beneficial effects on glucose
uptake mainly in insulin resistant conditions, although
the exact mechanisms underlying these adaptations have
yet to be clarified. Interestingly, Eijnde et al. [30] showed
that Cr intake increases GLUT-4 protein content in line
with glycogen accumulation during muscle disuse and a
subsequent period of training, suggesting a role of GLUT-
4 in Cr-induced glucose uptake enhancement.
Kreider et al. [4] also reported an improvement in the
lipid profile of professional football players following Cr
supplementation (15.75 g·day -1) during 28 days of high
intensity training. The supplemented group presented a
significant increase in HDL-cholesterol (13%), and a sig-
nificant decrease in both triglycerides and VLDL-choles-
terol (-13%), compared to the placebo group, showing an
additive effect of Cr supplementation. Accordingly, Arci-
ero et al. [5] showed that intense strength training in con-
junction with Cr supplementation (25 g·day -1 for 7 days
followed by 5 g·day-1 for 11 weeks) significantly
decreased total cholesterol values (-9.9%) when com-
pared to strength training only. Their results reinforced
the hypothesis that Cr supplementation had an additive
effect to training effects on the lipid profile. A possible
explanation for this phenomenon was that Cr supplemen-
tation enhanced training quality indirectly (i.e. by opti-
mizing volume and intensity). In a review manuscript,
Durstine et al. [31] suggested that the lipid profile
improved incrementally with training volume and inten-
sity. Therefore, as Cr supplementation allowed subjects to
train at a higher intensity/volume, then the training itself
may have enhanced the effect and not the supplementa-
tion per se.
Cr supplementation is reported to be effective mainly in
the improvement of performance during sustained or
intermittent high intensity exercise and not in aerobic
training [25]. Whilst Cr supplementation has not been
shown to increase performance in moderate intensity aer-
obic activity, Walsh et al. [13] have suggested a mechanis-
tic role for Cr in the stimulation of mitochondrial
oxidative phosphorylation which clearly could have
impact on the relative utilization of carbohydrate and fat
as fuel sources, and indirectly could affect the plasma lipid
profile. Whilst an attractive hypothesis, our observations
do not support any such effect of Cr supplementation.
Table 3: Fasting glucose (mg/dl), insulin (μUl/ml) and Homa index.
PRE POST 4 POST 8 POST 12
Fasting glucose
CR 77,7 ± 11,7 70,4 ± 8,7 67,2 ± 11,4 68,8 ± 17,3
PL 77 ± 10,8 72 ± 6,7 65 ± 12,4 76,4 ± 12,4
Fasting insulin
CR 11.96 ± 5.95 13.89 ± 7.39 15.66 ± 4.54 15.32 ± 6.17
PL 13.54 ± 6.87 12.57 ± 3.76 14.43 ± 4.77 14.59 ± 8.32
HOMA
CR 2.47 ± 1.36 2.68 ± 0.61 2.71 ± 1.06 2.13 ± 1.07
PL 2.14 ± 0.59 2.11 ± 0.64 2.48 ± 0.90 2.58 ± 1.53
Fasting glucose, fasting insulin and Homa index for the CR (n = 12) and PL (n = 10) groups at Pre and 4, 8 and 12 week-post periods. The analysis 
of variance did not show significant differences.
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Volek et al. [18] similarly failed to observe any effect on
the lipid profile of three months Cr supplementation and
periodized resistance training. Arciero et al. [5] suggested
that the lack of change in lipid profile after resistance
training in Volek's study might have been a consequence
of the low dose of Cr used (5 g·day-1). However, in our
study we provided ~10 g·day-1 and again no difference
between the placebo and the Cr group was observed.
Thus, whilst exercise is clearly important in determining
the plasma lipid profile, Cr itself does not appear to have
any additional effect in healthy males.
Conclusion
Cr supplementation did not have any additive effect on
the plasma lipid profile of healthy sedentary males under-
going moderate intensity aerobic training for 3 months.
These results may appear contradictory to those of Earnest
et al. [7] although we emphasise that this earlier study was
carried out on hypercholesterolemic subjects, whereas
ours were normocholesterolemic. Notwithstanding the
lack of benefits in this present study we would suggest that
additional studies should be carried out to investigate any
indirect effect of Cr supplementation on the lipid profile
as a result of subjects being able to train at a higher inten-
sity.
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